Brief: RaQualia Pharma says termination of 5-HT4 partial agonist related license agreement

RaQualia Pharma

28/12/2017 06:27

Dec 28 (Reuters) - RaQualia Pharma Inc  4579.T   
    
    * Says co and South Korea-based firm CJ HealthCare terminate 
5-HT4 
partial agonist (RQ-00000010) related license agreement  
 
    Source text in Japanese: https://goo.gl/Q7i2tF 
    Further company coverage: 4579.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))